Naratriptan
From Wikipedia, the free encyclopedia
|
Naratriptan
|
|
| Systematic (IUPAC) name | |
| N-methyl-2-[3-(1-methyl-4-piperidyl )-1H-indol-5-yl]-ethanesulfonamide |
|
| Identifiers | |
| CAS number | |
| ATC code | N02 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H25N3O2S |
| Mol. mass | 335.465 g/mol |
| Pharmacokinetic data | |
| Bioavailability | 74% |
| Metabolism | Hepatic |
| Half life | 5-8 hours |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. | |
| Legal status |
℞ Prescription only |
| Routes | Oral |
Naratriptan (trade name Amerge) is a triptan drug developed by Glaxo Wellcome Inc. and is used for the treatment of migraine headaches. Naratriptan is available in 2.5 mg tablets. It is a selective 5-hydroxytryptamine1 receptor subtype agonist. Naratriptan hydrochloride is chemically designated as N-methyl-3-( 1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide.
Some side effects of the drug include vision changes, tingling sensations, tiredness or weakness, upset stomach, dizziness, and warm/cold temperature sensations. The U.S. Food and Drug Administration (FDA) approved naratriptan on February 11, 1998.
[edit] Side effects
Side effects include: dizziness, drowsiness, tingling of the hands or feet, unusual tiredness, nausea, dry mouth and unsteadiness. If these effects persist or worsen, notify your doctor promptly. Side-effects which are unlikely and which should be promptly reported include: chest pain/pressure, throat pain/pressure, unusually fast/slow/irregular pulse, one-sided muscle weakness, vision problems, cold/bluish hands or feet, stomach pain, bloody diarrhea, mental/mood changes, and fainting. In the unlikely event you have a serious allergic reaction to this drug, seek immediate medical attention. Symptoms of a serious allergic reaction include: rash, itching, swelling, severe dizziness, trouble breathing.
|
||||||||||||||
|
|||||

